Tevis Investment Management Virios Therapeutics, Inc. Transaction History

Tevis Investment Management

  • $132 Million
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 08, 2022
BUY
$3.31 - $4.89 $248 - $366
75 New
75 $0
Q1 2022

Aug 05, 2022
SELL
$4.48 - $6.92 $336 - $519
-75 Closed
0 $0
Q4 2021

Aug 05, 2022
BUY
$4.07 - $6.12 $305 - $459
75 New
75 $1,000

Others Institutions Holding VIRI

# of Institutions
6
Shares Held
79.3K
Call Options Held
0
Put Options Held
0
View Full List

About Virios Therapeutics, Inc.

VIRI Quotes by TradingView
  • Ticker VIRI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 18,330,400
  • Market Cap $81.4M
  • Description
  • Virios Therapeutics, Inc., a development-stage biotechnology company, focuses on developing antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. The company's lead development candidate is the IMC-1, a fixed dose combination of famciclovir and celecoxib to treat fibromyalgia. It is also developing IMC...
More about VIRI
Track This Portfolio

Track Tevis Investment Management Portfolio

Follow Tevis Investment Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tevis Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Tevis Investment Management with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email